177Lutetium-PSMA | Clinical Trials Search

1,766 results for “177Lutetium-PSMA”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

45 participants · First posted Aug 28, 2024

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

15 participants · First posted Nov 24, 2023

Not yet recruiting

Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timing of Response

280 participants · First posted Jun 12, 2026

PRINCE (PSMA-lutetium Radionuclide Therapy and ImmuNotherapy in Prostate CancEr)

37 participants · First posted Sep 5, 2018

Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

120 participants · First posted Sep 19, 2024

Radiopharmaceutical Treatment of Advanced Kidney Cancer

48 participants · First posted Jan 20, 2025

Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer

80 participants · First posted Jun 17, 2024

Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial

100 participants · First posted Dec 6, 2024

External Beam and Radioligand Radiotherapy for mCRPC

120 participants · First posted Jan 21, 2026

Not yet recruiting

Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

1,330 participants · First posted Jul 17, 2026

Page 1 of 117